NCT01404208View on ClinicalTrials.gov

2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD

NACompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2015

Study Completion Date

December 31, 2016

Conditions
Obsessive-Compulsive Disorder
Interventions
DRUG

D-Cycloserine

25mg dose for children weighing between 22.5kg and 45kg (dose = approx. .7mg/kg) 50mg dose for children weighing greater than 46kg (dose = approx. .7mg/kg) Dose given 7 times, every seven days, except for the third dose, which will be given three days after the second dose. All doses given 1 hour prior to therapy session.

DRUG

Placebo

Sugar pill

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

University of South Florida

OTHER

lead

Massachusetts General Hospital

OTHER

NCT01404208 - 2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD | Biotech Hunter | Biotech Hunter